Emergency measures have helped keep economies alive, but could have nasty side-effects in the long term
- Slow jobs growth may not be a bad sign for America’s recovery
- Does the Medline mega-deal herald the return of giant buyouts?
- Why the market for secondhand private-equity stakes is thriving
- Covid-19 has given South Korea’s biotech firms a shot in the arm
- Will empty shopfronts revive as New York comes back to life?